title: Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.
authors.affiliation: Division of Infectious Diseases, Wayne State University, 4201 St. Antoine, UHC 7D, Detroit, MI, 48201, USA, rmacarthur@med.wayne.edu.
authors.forename: Rodger D
authors.initials: RD
authors.lastname: Macarthur